Sonia Poli PhD

Sonia is an accomplished R&D professional with more than 20 years of progressive international experience in private and publicly listed pharmaceutical companies. She has broad expertise which encompasses multiple therapeutic areas, in large indications as well as rare orphan indications, with the main focus in psychiatric and neurodegenerative diseases.

Sonia has an established track record of leading projects through key scientific, regulatory and partnership milestones. She served in leadership and executive positions at Hoffmann la Roche, Addex and AC Immune and sits on the Board of Directors of Dimerix. She holds a Ph.D. in Industrial Chemistry from the University of Milan and she is a co-author of several patents and more than 50 scientific publications.